Does NITROGLYCERIN Cause Hepatocellular injury? 21 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Hepatocellular injury have been filed in association with NITROGLYCERIN (Glonoinum). This represents 0.3% of all adverse event reports for NITROGLYCERIN.
21
Reports of Hepatocellular injury with NITROGLYCERIN
0.3%
of all NITROGLYCERIN reports
21
Deaths
21
Hospitalizations
How Dangerous Is Hepatocellular injury From NITROGLYCERIN?
Of the 21 reports, 21 (100.0%) resulted in death, 21 (100.0%) required hospitalization, and 21 (100.0%) were considered life-threatening.
Is Hepatocellular injury Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NITROGLYCERIN. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does NITROGLYCERIN Cause?
Drug ineffective (1,269)
Fall (1,183)
Hypotension (1,086)
Pain (952)
Constipation (896)
Headache (890)
Dyspnoea (801)
Malaise (765)
Dizziness (717)
Fatigue (680)
What Other Drugs Cause Hepatocellular injury?
ACETAMINOPHEN (1,761)
METHOTREXATE (683)
ATORVASTATIN (610)
SULFAMETHOXAZOLE\TRIMETHOPRIM (415)
ENOXAPARIN (365)
TRAMADOL (349)
AMOXICILLIN (347)
ESOMEPRAZOLE (341)
PANTOPRAZOLE (340)
VINCRISTINE (306)
Which NITROGLYCERIN Alternatives Have Lower Hepatocellular injury Risk?
NITROGLYCERIN vs NITROUS
NITROGLYCERIN vs NITROUS\OXYGEN
NITROGLYCERIN vs NIVOLUMAB
NITROGLYCERIN vs NIVOLUMAB\RELATLIMAB-RMBW
NITROGLYCERIN vs NIZATIDINE